May, 10 2011, 01:07pm EDT
Environmental Leaders to AEP: What's Your Number?
National environmental groups the Natural Resources Defense Council, Environmental Defense Fund and Sierra Club are launching a new campaign today that challenges American Electric Power (AEP) to publicly name the number of lives it wants Congress to sacrifice to give AEP and other polluters delays and rollbacks of national limits on toxic air pollution.
WASHINGTON
National environmental groups the Natural Resources Defense Council, Environmental Defense Fund and Sierra Club are launching a new campaign today that challenges American Electric Power (AEP) to publicly name the number of lives it wants Congress to sacrifice to give AEP and other polluters delays and rollbacks of national limits on toxic air pollution.
While other utilities are investing in technology and jobs to clean up toxic air pollution from coal-fired power plants and meet new national pollution standards on time, AEP is promoting on Capitol Hill a sweeping, 56-page bill it drafted to weaken and delay federal clean air standards. AEP lobbyists wrote the bill, dubbed it the Electric Power Regulatory Coordination Act of 2011, and then went looking for lawmakers to sponsor it.
Columbus, Ohio-based AEP is one of the largest emitters of toxic air pollution in the country. In 2008, AEP emitted more mercury, nitrogen oxide, and carbon dioxide pollution than any other American utility.
If the AEP bill were to become law, in the first two years alone it would permit the release of mercury, acid gases, and arsenic that would contribute to as many as 34,000 deaths, 220,000 asthma attacks, and 1.5 million missed work days - severe health impacts that would be avoided by implementation of EPA's recently proposed clean air standards for the nation's most toxic pollutants.
Statements of Environmental Leaders:
"Instead of promoting a big polluters' bill of rights to delay scientists from issuing updates that protect our health, AEP should be cleaning up its deadly pollution and looking for clean energy alternatives," said Frances Beinecke, president of the Natural Resources Defense Council. "Investing in clean energy would not only protect countless American lives but help create jobs and boost the economy."
"Today we are asking AEP a simple question: What's your number? What's the acceptable number of American lives to surrender?" said Environmental Defense Fund President Fred Krupp. "After twenty years of delay, AEP wants America to wait another six years before we limit toxic mercury from some power plants - and they want to delay limits on a host of other dangerous pollutants."
"AEP made $1.2 billion in profits last year -- while America's children suffered asthma hospitalizations and mercury-related developmental delays," said Krupp. "This draft bill represents Washington at its worst: corporate lobbyists writing legislation to block limits on toxic pollution and then shopping around for Members of Congress to sponsor it. We'll see who is willing to put their name on it and put their constituents' health at risk."
"Corporate polluters like AEP have stooped to a new low in their efforts to keep their profits flowing at the expense of millions of Americans' health. AEP wants a license to kill and they need to be stopped, said Michael Brune, executive director of the Sierra Club.
"AEP says that 'strong environmental performance is essential to fulfilling our corporate social responsibilities,'" added Krupp. "If that's true, the company should stop trying to sell this dirty air bill, and get back to work."
Background on Draft AEP Legislation
A HEALTH WRECK FOR AMERICA'S CHILDREN
A 56-page discussion draft circulated on April 29, 2011 (dubbed the "Electric Power Regulatory Coordination Act of 2011") would halt implementation of the nation's clean air laws for the nation's single largest source of air pollution: fossil fueled power plants. The abstruse legal language set out in the 56 page document would rip apart the fabric of our nation's clean air laws. If it became law, the discussion draft would allow harmful air pollution would persist for years longer, imposing a heavy health burden on America's children:
- In the first two years alone, the pollution allowed under the discussion draft is associated with as many as 34,000 deaths, 220,000 asthma attacks, and 1.5 million missed work and sick days,* health-harming impacts that would be prevented by timely implementation of EPA's proposed clean air standards for the nation's most toxic pollutants.
- For over a decade, the discussion draft categorically bars EPA from taking action to (1) limit power plant emissions of arsenic, chromium, and acid gases, (2) protect human health imperiled by interstate air pollution transport discharged by coal-fired power plants, (3) reduce the haze pollution in America's premier national parks, and (4) finalize proposed emission standards to reduce power sector sulfur dioxide pollution, which transforms into lethal particulates.
- The discussion draft would halt the application of clean air protections under two landmark Supreme Court cases, Massachusetts v. EPA and Environmental Defense v. Duke Energy, to power plant pollution by, for example, prohibiting significant reductions in climate-disrupting pollution from the nation's existing coal plants for over a decade; these facilities are the nation's single largest source of climate pollution, discharging 1.8 billion tons of carbon dioxide annually and 4.9 million tons daily.
While AEP and some other power companies are seeking to erode bedrock clean air protections, other major utilities are supporting healthier air for America:
- Dick Kelly, Chairman of the Edison Electric Institute, Xcel CEO and Chairman: "Pursuing emission reductions for several years positions us to meet future environmental goals, and we have a variety of tools which we can do that with"; "we do have the foundations for a very, very successful future." [Dec. 1, 2010 Investor Meeting]
- William Johnson, President and CEO, Progress Energy on the proposed merger of Duke Power and Progress: "As a result of these combined actions, we believe the new company will be well positioned to meet the new EPA MACT regulations expected later this year and in to 2012. We still have much work to do to comply with these rules, which could require significant additional capital investment and additional announced plant closures. However, we are further down the road on compliance than many other companies with large coal fleets. We should also benefit by combining best practices in our fleet modernization efforts." [Jan. 10, 2011 Investor Meeting]
- Peter Darbee, Chairman, President and CEO, PG&E Corp.; Jack Fusco, President and CEO, Calpine Corp.; Lewis Hay, Chairman and CEO, NextEra Energy, Inc.; Ralph Izzo, Chairman, President and CEO, Public Service Enterprise Group, Inc.; Thomas King, President, National Grid USA; John Rowe, Chairman and CEO, Exelon Corp.; Mayo Shattuck, Chairman, President and CEO, Constellation Energy Group: "The electric sector has known that these rules were coming. Many companies, including ours, have already invested in modern air-pollution control technologies and cleaner and more efficient power plants. For over a decade, companies have recognized that the industry would need to install controls to comply with the act's air toxicity requirements, and the technology exists to cost effectively control such emissions, including mercury and acid gases." [Dec. 8, 2010 Wall Street Journal letter to the editor]
The nation's largest power companies are financially well positioned to comply with these important health protections. In 2010, the top ten power companies by generating capacity [MWh] had a combined $28.4 billion in profits and $7.5 billion in cash balances.
*The proposed AEP legislation would delay and weaken new EPA standards to address the most toxic contaminants at power generation facilities nationwide. EPA has estimated that in 2016 the annual particulate matter-related benefits of the proposed rule for adults will "include approximately 6600 to 17,000 fewer premature mortalities, 4,300 fewer cases of chronic bronchitis, 10,000 fewer non-fatal heart attacks, 12,000 fewer hospitalizations (for respiratory and cardiovascular disease combined), 4.9 million fewer days of restricted activity due to respiratory illness and approximately 830,000 fewer lost work days. We also estimate substantial health improvements for children in the form of 110,000 fewer asthma attacks, 6,700 fewer hospital admissions due to asthma, 10,000 fewer cases of acute bronchitis, and approximately 210,000 fewer cases of upper and lower respiratory illness." 76 Fed. Reg. 24,976, 26,090 (May 3, 2011) If AEP has its way and the rules are blocked, all of those projected annual benefits would be lost for at least two years, with ongoing harm in subsequent years as well.
NRDC works to safeguard the earth--its people, its plants and animals, and the natural systems on which all life depends. We combine the power of more than three million members and online activists with the expertise of some 700 scientists, lawyers, and policy advocates across the globe to ensure the rights of all people to the air, the water, and the wild.
(212) 727-2700LATEST NEWS
Sanders Praises FTC Challenge of 'Junk' Patents for Drugs Including Ozempic
"We can no longer tolerate Novo Nordisk charging the American people $969 for Ozempic when that same exact drug can be purchased for just $155 in Canada and $59 in Germany while it costs less than $5 to manufacture."
Apr 30, 2024
U.S. Sen. Bernie Sanders on Tuesday lauded the Biden administration for expanding its "campaign against pharmaceutical manufacturers' improper or inaccurate listing of patents" for a wide range of drugs including Novo Nordisk's Ozempic.
"Let me commend the Federal Trade Commission, under the leadership of Chair Lina Khan, for taking bold action today against the bogus patents Novo Nordisk has filed to prevent Americans struggling with diabetes from receiving a generic version of Ozempic at a much lower price," Sanders (I-Vt.) said in a statement.
Sanders—who leads the Senate Health, Education, Labor, and Pensions (HELP) Committee—stressed that "Novo Nordisk must not be allowed to make billions in profits by delaying generic competition for Ozempic by unlawfully filing junk patents that have nothing to do with the drug itself, but the injection pen."
"Last week, the HELP Committee, that I chair, launched an investigation into the outrageously high prices Novo Nordisk is charging for Ozempic and Wegovy in the United States," he noted. The former name is used when the patient is taking the medication for Type 2 diabetes and the latter is used when it is prescribed to treat obesity in adults with at least one weight-related comorbidity.
"In my view, we can no longer tolerate Novo Nordisk charging the American people $969 for Ozempic when that same exact drug can be purchased for just $155 in Canada and $59 in Germany while it costs less than $5 to manufacture," said the senator. "I look forward to working with the Biden administration to take on the greed of Novo Nordisk and substantially reduce the price of Ozempic and other prescription drugs."
After disputing more than 100 patents in the Food and Drug Administration's (FDA) Orange Book in November, the FTC on Tuesday sent warning letters to 10 companies and notified the agency that it challenges the accuracy or relevance of over 300 listing across 20 different brand name products.
In addition to Denmark-based Novo Nordisk, the FTC sent letters to Amphastar Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Covis Pharma, Glaxo-Smith Kline, Novartis Pharmaceuticals, Teva Pharmaceutical Industries, and some subsidiaries for asthma, chronic obstructive pulmonary disease (COPD), diabetes, and weight loss drugs.
"By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs, forcing Americans to pay sky-high prices for medicines they rely on," said Khan. "By challenging junk patent filings, the FTC is fighting these illegal tactics and making sure that Americans can get timely access to innovative and affordable versions of the medicines they need."
Sanders was not alone in praising the commission and its leader—an appointee of President Joe Biden—for the ongoing efforts to battle Big Pharma's greed.
Public Citizen's Access to Medicines program advocate, Steve Knievel, said that "it's becoming harder for drug corporations to use patent shenanigans to thwart competition, thanks to the FTC and Chair Lina Khan."
"Improperly listing patents in the FDA Orange Book stymies generic competition, which is proven to dramatically lower prescription drug prices, saving patients and the public billions of dollars," he said, echoing Khan. "Today's letter is yet another demonstration from the Biden-Harris administration that Big Pharma business-as-usual monopoly abuses and price gouging will not be tolerated."
"The FDA should supplement FTC's action by clarifying guidelines for patents that can be listed in the Orange Book," he continued, noting that such action has been proposed by Sen. Elizabeth Warren (D-Mass.) and Rep. Pramila Jayapal (D-Wash.). "The government should also explore using licensing authorities to overcome pharmaceutical monopoly abuses, leaving no option off the table."
Keep ReadingShow Less
As Biden Plans to Reschedule Marijuana, Advocates Say 'Fully Legalize' It
Sen. Cory Booker urged fellow lawmakers to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
Apr 30, 2024
U.S. marijuana legalization advocates greeted Tuesday's news that the Drug Enforcement Administration is proposing rescheduling cannabis to a less restrictive class by calling on President Joe Biden to fully deschedule the plant, which is approved for recreational or medicinal use in the vast majority of states.
The Associated Pressreported the DEA is proposing rescheduling marijuana from Schedule I—which includes heroin, MDMA, and LSD—to Schedule III, a far less restrictive class that includes ketamine, anabolic steroids, testosterone, and over-the-counter products containing less than 90 milligrams of codeine per dose. According to the DEA, Schedule I drugs have "no currently accepted medical use and a high potential for abuse."
While it would not legalize cannabis for recreational use, the DEA proposal—which is subject to review by the White House Office of Management and Budget—would affirm medicinal marijuana and recognize that the plant has a lower potential for abuse than other widely used recreational drugs.
The Drug Policy Alliance (DPA)—which works to end the failed 53-year War on Drugs—warned that "under this proposed shift, marijuana criminalization would continue at the federal level and most penalties, including those for simple possession, would continue as long as marijuana remains anywhere on the Controlled Substances Act (CSA)."
While running for president in 2020, Biden repeatedly vowed to decriminalize marijuana and expunge the criminal records of people convicted of cannabis possession. In 2022 the president issued a "full, complete, and unconditional pardon to all current United States citizens and lawful permanent residents" convicted of simple federal marijuana possession—a move that affected thousands of people but excluded those who are in the United States without authorization.
The following year, Health and Human Services (HHS) Secretary Xavier Becerra confirmed that his department would recommend rescheduling cannabis to Schedule III.
Sen. Cory Booker (D-N.J.) on Tuesday urged Congress to "follow the lead of states around the country and legalize cannabis for adult use and create a comprehensive taxation and regulatory scheme."
"Thousands of people remain in prisons around the country for marijuana-related crimes. Thousands of people continue to bear the devastating collateral consequences that come with a criminal record," the senator continued. "Legal marijuana businesses, especially those in communities hardest hit by the War on Drugs, still have to navigate a convoluted patchwork of state laws and regulatory schemes."
"I hope that my colleagues on both sides of the aisle, especially those who represent constituents benefiting from medical or adult-use programs, join me to pass federal legislation to fix these problems," Booker added.
Senate Majority Leader Chuck Schumer (D-N.Y.) said that "it is great news that DEA is finally recognizing that restrictive and draconian cannabis laws need to change to catch up to what science and the majority of Americans have said loud and clear."
"While this rescheduling announcement is a historic step forward, I remain strongly committed to continuing to work on legislation like the SAFER Banking Act as well as the Cannabis Administration and Opportunity Act, which federally deschedules cannabis by removing it from the Controlled Substances Act," he added.
Booker and Schumer were among the 21 senators who last week sent a letter to U.S. Attorney General Merrick Garland and DEA Administrator Anne Milgram noting that it's been 18 months since Biden ordered HHS October to review cannabis scheduling and eight months since the agency's rescheduling recommendation.
"While we understand that the DEA may be navigating internal disagreement on this matter, it is critical that the agency swiftly correct marijuana's misguided placement in Schedule I," the letter states.
Legalization advocates, meanwhile, pushed the Biden administration to go much further, as 24 states plus the District of Columbia have approved adult-use recreational marijuana and 38 states have legalized medicinal cannabis.
"Supporting federal marijuana decriminalization means supporting the removal of marijuana from the Controlled Substances Act, not changing its scheduling," DPA director of drug markets and legal regulation Cat Packer said in a statement. "We all deserve a federal framework for marijuana that upholds the health, well-being, and safety of our communities—particularly Black communities who have borne the brunt of our country's racist enforcement of marijuana laws."
"Rescheduling marijuana is not a policy solution for federal marijuana criminalization or its harms, and it won't address the disproportionate impact that it has had on Black and Brown communities," Packer added.
Dasheeda Dawson, chair of the Cannabis Regulators of Color Coalition and founder of Cannabis NYC, said: "The time for descheduling cannabis is not just a matter of policy; it's an imperative for justice and equity. Rescheduling would undermine the hard-fought progress made by cannabis equity and policy reform leaders like the Cannabis Regulators of Color Coalition, jeopardizing the livelihoods and futures of those entrepreneurs and communities disproportionately affected by past criminalization."
"We cannot afford to backtrack on our commitment to repair the harm inflicted by outdated policies," Dawson added. "Descheduling is not just about legality; it's about rectifying historic injustices and ensuring a fair and inclusive future for all."
Keep ReadingShow Less
G7 2035 Coal Phaseout Pledge Called 'Too Little, Too Late' to Match Climate Emergency
"If they are serious and aligned with what the science says is needed to keep 1.5°C within reach, G7 countries must ditch this dinosaur, planet-wrecking fuel no later than 2030," one advocate said.
Apr 30, 2024
The Group of Seven Climate, Energy, and Environment Ministerial concluded a meeting in Turin, Italy, on Tuesday with a commitment to phase out "unabated" coal use by 2035.
While the agreement is "unprecedented" for the U.S. and Japan, which had not previously set an expiration date on their burning of the dirtiest fossil fuel, it still does not align with the Paris agreement goal of limiting global heating to 1.5°C.
"The commitment to phase out coal is simply too little, too late. If they are serious and aligned with what the science says is needed to keep 1.5°C within reach, G7 countries must ditch this dinosaur, planet-wrecking fuel no later than 2030," Greenpeace International global climate politics expert Tracy Carty said in a statement. "And the climate emergency demands they just don't stop at coal. Fossil fuels are destroying people and planet and a commitment to rapidly phase out all fossil fuels—coal, oil, and gas—is urgently needed."
"This is not the goal for coal we need, and it will not deliver climate justice."
In their Climate, Energy, and Environment Ministers' Meeting Communiqué, the countries agreed to "phase out existing unabated coal power generation in our energy systems during the first half of 2030s or in a timeline consistent with keeping a limit of 1.5°C temperature rise within reach, in line with countries' net-zero pathways."
The agreement comes days after the U.S. Environmental Protection Agency finalized a rule mandating that all coal plants that plan to operate after 2039 must slash their climate-heating emissions by 90% by that date. Like the "unabated" language in the G7 communiqué, the EPA plan leaves open the possibility that coal plants could continue to run if they can effectively eliminate their carbon dioxide pollution with carbon capture and storage. However, this is an unproven technology that has not succeeded at scale; for example, Oil and Gas Watch News reported last Thursday that a taxpayer-funded CCS project at an ethanol plant in Illinois had only captured up to 10-12% of CO2 emissions each year for the past decade.
"It is past time that the U.S. made concrete commitments to phase out coal power," Jeff Ordower, the director of 350.org North America director, said in a statement. He added that while 350.org welcomed "this and all steps toward phasing out fossil fuels, such as the Environmental Protection Agency's recent announcement to further limit coal-fired power plants' CO2 emissions, we must not lose sight of what is really at stake."
Further, Ordower said that the U.S.' plans "must not rely on unproven technologies like carbon capture, or dangerous, expensive, and unequal ones like nuclear just so they can continue business as usual."
Similarly, 350.org Japan campaigner Masayoshi Iyoda said, "Japan agreeing to a specific deadline to phase out domestic coal power generation is momentous and long overdue."
"As an historic outlier among G7 countries on making coal phaseout commitments, and with the highest share of power generated from coal among its G7 peers, this is a step forward. However, 2035 is too late to meet the 1.5°Ctarget set in the Paris agreement," Iyoda continued.
"This was the first opportunity for the G7 to show they were taking the COP28 agreement seriously. They have failed."
Amnesty International also criticized the timeline of the deal.
"This is not the goal for coal we need, and it will not deliver climate justice," Candy Ofime, Amnesty International's climate justice researcher, said in a statement. "Commitments put forward by G7 members—which have burnt coal for power for more than a century—to stop using this pollutant by 2035 are simply too late and weakened by unacceptable caveats."
Ofime pointed out that the deal appeared to make no mention of phasing out coal in steel production, despite the fact that the process burns up around 30% of total coal use. She also argued that the language around "unabated" coal use was "misleading."
"Abatement relies on the use of carbon capture and storage, and other technologies such as ammonia and hydrogen co-firing with coal, which are unproven at scale and can come with other risks," Ofime sad. "Coal pollution cannot be adequately abated, and harms health and the climate whenever it is used."
Campaigners also criticized the G7 countries for focusing their timeline on coal and not oil and gas, especially since all nations agreed to work toward "transitioning away from fossil fuels in energy systems, in a just, orderly, and equitable manner" at last year's COP28 United Nations climate talks in Dubai.
"This was the first opportunity for the G7 to show they were taking the COP28 agreement seriously. They have failed," said Romain Ioualalen, Oil Change International's global policy campaign manager.
Oil Change pointed out that G7 countries are responsible for nearly half of all CO2 emissions from new oil and gas production, as well as 27% of production overall. At the same time, they subsidized fossil fuels to the tune of $25.7 billion a year between 2020 and 2022, compared to only $10.3 billion for renewables. While the countries did reaffirm a pledge to end "inefficient" fossil fuel subsidies by 2025 or earlier, they did not offer any more details on the timeline.
"While the G7 focuses on coal, it conveniently omits to stress that limiting warming to 1.5°C means they also need to end fossil fuel expansion at home, going fastest in phasing out existing production," Ioualalen said. "They must end the billions of dollars in taxpayer finance still flowing to fossil fuel projects abroad and fund the buildout of affordable renewable energy on fair terms. If their oil and gas expansion plans are allowed to proceed, it would lock in climate chaos and an unlivable future."
The ministers also reaffirmed the importance of natural gas deliveries to Europe to help it replace Russian gas in the wake of Russia's ongoing war on Ukraine. However, European officials have said that they will have enough gas supplies to last through the next decade despite a Biden administration pause on new liquefied natural gas (LNG) export approvals.
"Faced with climate catastrophe, the G7's persistent endorsement of fossil gas is alarming," Carty of Greenpeace said. "Gas is not needed, not cheap, and is certainly not a 'bridge fuel' to a safe climate. The biggest fossil fuel threat today by wealthy nations is coming from the rapidly expanding LNG industry. An urgent shift is needed towards less, not more, gas—and massively expanded renewables."
Keep ReadingShow Less
Most Popular